STAAR Surgical Company STAA
NASDAQ
| 07/03/2026 | 04/03/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.01% | 61.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.01% | 61.80% | |||
| Cost of Revenue | -3.47% | 75.41% | |||
| Gross Profit | 1.26% | 57.42% | |||
| SG&A Expenses | 19.66% | -8.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.61% | 10.68% | |||
| Operating Income | -41.75% | 260.28% | |||
| Income Before Tax | 34.14% | 139.79% | |||
| Income Tax Expenses | -1.53% | 228.55% | |||
| Earnings from Continuing Operations | 54.78% | 128.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.78% | 128.43% | |||
| EBIT | -41.75% | 260.28% | |||
| EBITDA | -35.81% | 320.10% | |||
| EPS Basic | 53.50% | 128.34% | |||
| Normalized Basic EPS | -38.03% | 301.00% | |||
| EPS Diluted | 60.00% | 127.17% | |||
| Normalized Diluted EPS | -38.23% | 297.09% | |||
| Average Basic Shares Outstanding | 0.83% | 0.30% | |||
| Average Diluted Shares Outstanding | 1.18% | 2.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||